Wealthfront Advisers LLC Moderna, Inc. Transaction History

Wealthfront Advisers LLC

$120 Billion
Q4 2024

A detailed history of Wealthfront Advisers LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 2,013 shares of MRNA stock, worth $64,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,013

Previous 12,911 84.41%

Holding current value

$64,154

Previous $862,000 90.37%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$36.85 - $63.93 $401,591 - $696,709	-10,898 Reduced 84.41%	2,013 $83,000
Q3 2024 Nov 12, 2024	SELL	$63.64 - $125.14 $583,706 - $1.15 Million	-9,172 Reduced 41.53%	12,911 $862,000
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $817,878 - $1.35 Million	8,081 Added 57.71%	22,083 $2.62 Million
Q1 2024 Apr 19, 2024	BUY	$85.37 - $115.44 $768,586 - $1.04 Million	9,003 Added 180.1%	14,002 $1.49 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $347,480 - $522,045	4,999 New	4,999 $497,000
Q1 2023 Apr 28, 2023	SELL	$135.66 - $197.02 $1.09 Million - $1.58 Million	-8,005 Reduced 32.27%	16,804 $2.58 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $1.85 Million - $3.29 Million	15,666 Added 171.34%	24,809 $4.46 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $727,547 - $1.2 Million	-6,162 Reduced 40.26%	9,143 $1.08 Million
Q2 2022 Jul 20, 2022	SELL	$117.13 - $176.59 $1.51 Million - $2.27 Million	-12,877 Reduced 45.69%	15,305 $2.19 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $697,932 - $1.3 Million	-5,519 Reduced 16.38%	28,182 $4.86 Million
Q4 2021 Jan 21, 2022	BUY	$225.82 - $368.51 $861,503 - $1.41 Million	3,815 Added 12.77%	33,701 $8.56 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $5.36 Million - $11.7 Million	24,157 Added 421.66%	29,886 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $744,254 - $1.35 Million	5,729 New	5,729 $1.35 Million

Others Institutions Holding MRNA

# of Institutions

903

Shares Held

234M

Call Options Held

10.6M

Put Options Held

18.5M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $12.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Moderna, Inc. Transaction History